Prognostic factors in multiple myeloma in a population-based trial
- 24 April 2009
- journal article
- clinical trial
- Published by Wiley in European Journal of Haematology
- Vol. 45 (4), 198-202
- https://doi.org/10.1111/j.1600-0609.1990.tb00457.x
Abstract
Prognostic factors have been tested in patients with multiple myeloma treated according to a randomized trial of standard therapy versus 5-drug combination therapy. The following population-based study included 92 patients with a median age of 70 yr. The median survival was 31 months. The Cox regression model was used to search for predictors of survival. The cut-off levels for blood analyses derived in earlier studies tended to select few patients in the high-risk groups, for example only 8% of the patients had hemoglobin (Hb) less than or equal to 7.5 g/dl. Lytic bone lesions in the pelvis or in the long bones, or spontaneous fractures and age greater than 70 yr gave prognostic information in addition to anemia and impaired renal function. The MRC staging system was a better prognostic tool than the Durie & Salmon stages. Palliative treatment regimens which take quality of life into account should be considered carefully in multiple myeloma patients greater than 70 yr.Keywords
This publication has 11 references indexed in Scilit:
- Multiple myeloma in central and northern Norway 1981-1982: A follow-up study of a randomized clinical trial of 5-drug combination therapy versus standard therapyEuropean Journal of Haematology, 2009
- The use of prognostic factors in clinical trialsCancer, 1986
- Report on the second myelomatosis trial after five years of follow-up.British Journal of Cancer, 1980
- Prognostic features in the third MRC myelomatosis trial.British Journal of Cancer, 1980
- Prognostic indexes for renal cell carcinomaEuropean Journal of Cancer (1965), 1980
- Prognostic Factors in Multiple MyelomaActa Haematologica, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Prognostic factors in multiple myelomaCancer, 1975
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958